Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Progressive multifocal leukoencephalopathy.

Literature DB >> 6503939

Progressive multifocal leukoencephalopathy.

Abstract

PML is a progressive opportunistic infection of the CNS caused by a commonly occurring virus that may become manifest in the context of reduced host resistance in persons of any age. The authors review the disease and its causes, including a discussion of treatment attempts and differential diagnoses.

Entities: Disease Gene Species

Mesh：

Substances：
Antibodies, Viral

Year: 1984 PMID： 6503939

Source DB: PubMed Journal: Neurol Clin ISSN： 0733-8619 Impact factor: 3.806

Keyword Cloud
Cited

91 in total

Review 1. Epidemiological evidence and molecular basis of interactions between HIV and JC virus.

Authors: J R Berger; A Chauhan; D Galey; A Nath
Journal: J Neurovirol Date: 2001-08 Impact factor: 2.643

2. Progressive Multifocal Leukoencephalopathy.

Authors:
Journal: Curr Treat Options Neurol Date: 2000-07 Impact factor: 3.598

Review 3. Progressive multifocal leukoencephalopathy and multiple sclerosis: lessons from natalizumab.

Authors: Annette Langer-Gould; Lawrence Steinman
Journal: Curr Neurol Neurosci Rep Date: 2006-05 Impact factor: 5.081

Review 4. Progressive multifocal leukoencephalopathy and newer biological agents.

Authors: Joseph R Berger
Journal: Drug Saf Date: 2010-11-01 Impact factor: 5.606

5. Role for tumor necrosis factor-α in JC virus reactivation and progressive multifocal leukoencephalopathy.

Authors: Hassen S Wollebo; Mahmut Safak; Luis Del Valle; Kamel Khalili; Martyn K White
Journal: J Neuroimmunol Date: 2010-12-24 Impact factor: 3.478

6. Natalizumab in the treatment of multiple sclerosis.

Authors: Ozgür Yaldizli; Norman Putzki
Journal: Ther Adv Neurol Disord Date: 2009-03 Impact factor: 6.570

7. Progressive multifocal leukoencephalopathy associated with brentuximab vedotin therapy: a report of 5 cases from the Southern Network on Adverse Reactions (SONAR) project.

Authors: Kenneth R Carson; Scott D Newsome; Ellen J Kim; Nina D Wagner-Johnston; Gloria von Geldern; Craig H Moskowitz; Alison J Moskowitz; Alain H Rook; Pankaj Jalan; Alison W Loren; Daniel Landsburg; Thomas Coyne; Donald Tsai; Dennis W Raisch; LeAnn B Norris; P Brandon Bookstaver; Oliver Sartor; Charles L Bennett
Journal: Cancer Date: 2014-04-25 Impact factor: 6.860